United States · Funded startup

Who invested in CG Oncology

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$238Mraised across 1 round since 2024, from 1 source

Latest round
Round, $238MDec 2024
Investors
5
See who backed them

The rounds

  1. Dec 2024

Founders and team

From CG Oncology's own website: 6 on the team.

  • Arthur KuanChairman, President & Chief Executive Officer
  • Jim DeToreChief Financial Officer
  • Josh PattersonGeneral Counsel & Chief
  • Swapnil BhargavaChief Technical Officer
  • Vijay KasturiChief Medical Officer
  • Christina RossiBiopharmaceutical Executive & Board Member

AdvisersSusan E. Graf

Everyone who backed them

RA Capital ManagementPrivate equity1round
Janus Henderson InvestorsPrivate equity1round
Foresite CapitalPrivate equity1round
TCGPrivate equity1round
TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list CG Oncology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Longitude CapitalVC firmPer its own site
Decheng CapitalVC firmPer its own site

Quick answers about CG Oncology

Who invested in CG Oncology?

CG Oncology's investors include RA Capital Management, Janus Henderson Investors, Foresite Capital, TCG and TCG Crossover.

How much has CG Oncology raised?

CG Oncology has raised $238M across 1 round since 2024.

When did CG Oncology last raise?

CG Oncology's most recent round was an Undisclosed round of $238M in Dec 2024.

What was CG Oncology's biggest round?

Its most recent round, $238M in Dec 2024, is also its largest on record.

Who backed CG Oncology first?

CG Oncology's first round on record, in Dec 2024, was backed by RA Capital Management, Janus Henderson Investors and Foresite Capital and 2 others.

What stage is CG Oncology at?

CG Oncology's latest named round is an Undisclosed round, in Dec 2024.

Where is CG Oncology based?

CG Oncology is based in the United States.

Companies like CG Oncology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.